Recombinant multi-species MOBKL3/MOB4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MOBKL3/MOB4 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene was identified based on its similarity with the mouse counterpart. Studies of the mouse counterpart suggest that the expression of this gene may be regulated during oocyte maturation and preimplantation following zygotic gene activation. Alternatively spliced transcript variants encoding distinct isoforms have been observed. Naturally occurring read-through transcription occurs between this locus and the neighboring locus HSPE1.[provided by RefSeq, Feb 2011]
The Alternative Names of target: 2610109B12Rik,2C4D,CGI-95,Class II mMOB1,MOB-like protein phocein,MOB1,MOB3,MOB4,MOBKL3,Mob1 homolog 3 (Mob3),Mob4,Mobkl1,Mobkl3,Mps one binder kinase activator-like 3,PHOCN,PREI3,Phocn,Prei3,Preimplantation protein 3,phocein

Target products collectionGo to MOBKL3/MOB4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP7154-Ag-1/ GM-Tg-hg-IP7154-Ag-2 Human MOBKL3/MOB4 protein Human
GM-Tg-rg-IP7154-Ag-1/ GM-Tg-rg-IP7154-Ag-2 Rat MOBKL3/MOB4 protein Rat
GM-Tg-mg-IP7154-Ag-1/ GM-Tg-mg-IP7154-Ag-2 Mouse MOBKL3/MOB4 protein Mouse
GM-Tg-cynog-IP7154-Ag-1/ GM-Tg-cynog-IP7154-Ag-2 Cynomolgus/Rhesus macaque MOBKL3/MOB4 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP7154-Ag-1/ GM-Tg-felg-IP7154-Ag-2 Feline MOBKL3/MOB4 protein Feline
GM-Tg-cang-IP7154-Ag-1/ GM-Tg-cang-IP7154-Ag-2 Canine MOBKL3/MOB4 protein Canine
GM-Tg-bovg-IP7154-Ag-1/ GM-Tg-bovg-IP7154-Ag-2 Bovine MOBKL3/MOB4 protein Bovine
GM-Tg-equg-IP7154-Ag-1/ GM-Tg-equg-IP7154-Ag-2 Equine MOBKL3/MOB4 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP7154-Ag-1/ GM-Tg-hg-IP7154-Ag-2; GM-Tg-rg-IP7154-Ag-1/ GM-Tg-rg-IP7154-Ag-2;
GM-Tg-mg-IP7154-Ag-1/ GM-Tg-mg-IP7154-Ag-2; GM-Tg-cynog-IP7154-Ag-1/ GM-Tg-cynog-IP7154-Ag-2;
GM-Tg-felg-IP7154-Ag-1/ GM-Tg-felg-IP7154-Ag-2; GM-Tg-cang-IP7154-Ag-1/ GM-Tg-cang-IP7154-Ag-2;
GM-Tg-bovg-IP7154-Ag-1/ GM-Tg-bovg-IP7154-Ag-2; GM-Tg-equg-IP7154-Ag-1/ GM-Tg-equg-IP7154-Ag-2
Products Name MOBKL3/MOB4 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name MOBKL3/MOB4
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine MOBKL3/MOB4 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.